April 21, 2026
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreApril 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreApril 21, 2026
According to market projections, the theranostics sector is expected to grow from USD 2.42 billion in 2024 to USD 10.21 billion by 2034, reflecting a CAGR of 15.46%. Technological advancements and boosting non-oncological applications are driving the global market expansion. North America led with its rising cancer cases and healthcare system....
April 21, 2026
Market insights predict, the infectious disease diagnostics industry is expected to grow from USD 25.01 billion in 2024 to USD 62.95 billion by 2034, driven by a CAGR of 9.67%.The market is growing due to healthcare providers seeking faster, more reliable detection methods to control outbreaks. Growing awareness, government initiatives, and technol...
April 21, 2026
Based on market forecasts, the point-of-care molecular diagnostics sector will expand from USD 4.05 billion in 2024 to USD 11.03 billion by 2034, experiencing a CAGR of 10.45%. The point-of-care molecular diagnostics market is expanding due to increasing decentralized healthcare as well as growing advancements in multiplex tests. North America le...
April 21, 2026
According to market projections, the global DNA test kits market, valued at USD 1.61 billion in 2024, is anticipated to reach USD 7.78 billion by 2034, growing at a CAGR of 17.04% over the next decade. The growing demand for early diagnosis and point-of-care diagnostics drives the market. North America dominated the global market owing to the prese...
April 21, 2026
Based on market forecasts, the global syphilis testing market, projected at USD 2.29 billion in 2024, is expected to reach USD 4.57 billion by 2034, growing at a CAGR of 6.85% over the forecast period. The market is expanding due to the global increase in syphilis cases and other sexually transmitted infections. Growth is further fueled by rising a...
April 21, 2026
Projections indicate that, the global preimplantation genetics diagnosis (PGD) market will increase from USD 67.79 million in 2024 to USD 144.19 million by 2034, experiencing a CAGR of 7.84% over the next 10 years. The preimplantation genetics diagnosis (PGD) market is expanding due to growing advancements as well as increasing IVF usage. North Ame...
April 21, 2026
According to market projections, the immunoassay sector is expected to grow from USD 35.61 billion in 2024 to USD 56.54 billion by 2034, reflecting a CAGR of 4.72%. Ongoing technological advances are propelling the global market growth. North America dominated the market due to a rise in demand for precision diagnostics, treatment, and R&D inve...
April 21, 2026
Projections indicate that, the U.S. immunoassay market will increase from USD 8.99 billion in 2024 to USD 14.22 billion by 2034, experiencing a CAGR of 4.93% over the next 10 years. The expansion of immunoassays in the U.S. goes beyond traditional diagnostics into areas like therapeutic drug monitoring, personalized medicine, and biomarker discover...
April 21, 2026
Market insights predict, the diagnostic testing industry is expected to grow from USD 203.3 billion in 2024 to USD 274.53 billion by 2034, driven by a CAGR of 3.04%. The rising prevalence of chronic and infectious diseases is estimated to drive the growth of the market. North America led the global market owing to its advanced healthcare infrastruc...
April 21, 2026
Projections indicate that, the global pathology laboratories market will increase from USD 380.95 billion in 2024 to USD 834.44 billion by 2034, experiencing a CAGR of 8.2% over the next 10 years. The market is growing due to the rising demand for early disease diagnosis and advanced diagnostic testing. North America leads the market due to technol...